The most commonly observed FGFR3 mutations in bladder cancer include S249C, Y373C, R248C, and G370C mutations.18 These mutations can occur either on the extracellular or transmembrane domains of the receptor, and ultimately lead to ligand-independent dimerization and activation. The gene discussed is FGFR3; the disease is urinary bladder cancer.